Edesa Biotech is trading at $6.96 (5.4%) up in after-hours trading, rebounding from a recent pullback despite a lack of fresh company-specific headlines.
- The move appears driven by the stock’s typical high volatility rather than a fundamental catalyst.
- The price action occurs against a backdrop of broader market weakness across major indices.
- No new earnings reports or FDA decisions have been released today to account for the move.